The Lorazepam Injection, cataloged under National Stock Number 6505-01-650-1467, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Amphastar Pharmaceuticals, Inc.. Government technical data includes 8 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-650-1467 |
| Primary Part Number | NDC76329-8261-01 |
| Item Name | Lorazepam Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Amphastar Pharmaceuticals, Inc. |
| Status | ACTIVE |
| Controlled Substance Classification | SCHEDULE IV |
| Administration | INTRAMUSCULAR OR INTRAVENOUS |
| Primary Container Content Quantity | 10.0 EACH |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Protective Storage Feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| Pharmaceutical Vehicle Type | AQUEOUS |
| Active Medicament Medicinal Strength | 10.0 MILLIGRAMS LORAZEPAM PER MILLILITER |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC76329-8261-01 PRIMARY | Amphastar Pharmaceuticals, Inc. (USA) |
| NDC00641-6046-10 PRIMARY | Hikma Pharmaceuticals Usa Inc. (USA) |
| NDC00641-6000-10 PRIMARY | Hikma Pharmaceuticals Usa Inc. (USA) |
| Reference | Meaning |
|---|---|
| 1389217 | 5/1 Secondary reference U.S. Government activity |
| NDC00409-6780-02 | 5/9 Secondary reference Hospira, Inc. |
| 6505NCM152482 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-650-1467 is a Lorazepam Injection, manufactured by Amphastar Pharmaceuticals, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-650-1467 has 3 manufacturer part numbers on file: NDC76329-8261-01 (Amphastar Pharmaceuticals, Inc.), NDC00641-6046-10 (Hikma Pharmaceuticals Usa Inc.), NDC00641-6000-10 (Hikma Pharmaceuticals Usa Inc.).
Key specifications for NDC76329-8261-01: Controlled Substance Classification: SCHEDULE IV; Administration: INTRAMUSCULAR OR INTRAVENOUS; Primary Container Content Quantity: 10.0 EACH; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 8 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.